SANDRA AGUAYO: Open Payments
NPI 1144900044 · BULLHEAD CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 25 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $237 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $137 |
| Lilly USA, LLC | 3 | $51 |
| SANOFI-AVENTIS U.S. LLC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Ascendis Pharma Endocrinology Inc | 1 | $25 |
| Corcept Therapeutics | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $19 |
| BETA BIONICS, INC. | 1 | $19 |
Products named: VRAYLAR, QULIPTA, TZIELD, MOUNJARO, SHINGRIX, Yorvipath, Korlym, XIFAXAN.
Industry payments across AZ — which companies pay providers there.
